untreated childhood visual pathway glioma
Showing 1 - 25 of >10,000
Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma Trial in Beijing (Carboplatin, Vincristine, Recombinant human
Recruiting
- Optic Glioma
- Pediatric Brain Tumor, Optic Nerve Glioma
- Carboplatin
- +2 more
-
Beijing, ChinaCapital Medical University Sanbo Brain Hospital
Jul 4, 2022
Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)
Completed
- Juvenile Pilocytic Astrocytomas
- Optic Pathway Gliomas
- Pegylated interferon alpha-2b
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jan 18, 2022
Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United
Completed
- Neurofibromatosis Type 1
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Los Angeles, California
- +11 more
Apr 22, 2022
Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma Trial in
Active, not recruiting
- Neurofibromatosis Type 1
- +2 more
- Lenalidomide
- Pharmacological Study
-
Birmingham, Alabama
- +125 more
Jan 25, 2023
Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)
Not yet recruiting
- Optic Pathway Glioma
- CHF6467
- Placebo
-
Rome, ItalyCatholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023
CNS Tumor, Pediatric, Chemo-induced Nausea and Vomiting, Child Solid Tumor Trial in Canada, United States (Real Acupressure
Completed
- Central Nervous System Tumor, Pediatric
- +2 more
- Real Acupressure Band
- Placebo Acupressure Band
-
Long Beach, California
- +24 more
Jul 19, 2021
Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)
Active, not recruiting
- Low-grade Glioma
- +2 more
-
Calgary, Alberta, Canada
- +6 more
Oct 25, 2022
Multi-Dimensional MRI Spatial Heterogeneity Analysis for
Not yet recruiting
- High-grade Glioma
- MR scanning; Clinical data collection
-
Shanghai, Shanghai, ChinaDepartment of Radiology, Renji hospital, School of Medicine, Sha
Aug 16, 2023
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Mobile Application Trial in Liège (TICOP)
Suspended
- Mobile Application
- TICOP
-
Liège, BelgiumUniversity of Liège (Unit: Health Psychology)
Nov 7, 2022
Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)
Not yet recruiting
- Low-grade Glioma
- DAY101
- Chemotherapeutic Agent
- (no location specified)
Oct 3, 2022
Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)
Not yet recruiting
- Glioma, Malignant
- Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
- Hiltonol
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023
NF1, Low-grade Glioma Trial in United States (Poly ICLC)
Recruiting
- NF1
- Low-grade Glioma
- Poly ICLC
-
Birmingham, Alabama
- +18 more
Jan 5, 2023
Amblyopia Trial in Cairo (eye patch, dichoptic treatment)
Completed
- Amblyopia
- eye patch
- dichoptic treatment
-
Cairo, EgyptAin Shams University Hospitals (Demerdash)
Nov 27, 2022
Glioma, Malignant Trial in Rom, Rome (histopathological analysis; morphological and non-morphological magnetic resonance)
Completed
- Glioma, Malignant
- histopathological analysis; morphological and non-morphological magnetic resonance
-
Rom, Roma, Italy
- +1 more
Mar 28, 2023
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
Recruiting
- Hepatitis C Virus Infection
- Contact the patient
-
Brussel, BelgiumUZ Brussel
Aug 1, 2023
Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States
Recruiting
- Recurrent Low Grade Astrocytoma
- +4 more
- Quality-of-Life Assessment
- +3 more
-
Birmingham, Alabama
- +64 more
Aug 20, 2022
High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)
Not yet recruiting
- High Grade Glioma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 6, 2023